Urology Doctors in Ames, IA Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Dr. Damon J. Dyche, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave.,, Mcfarland Clinic, Pc, Ames, IA 50010 Phone: 515-239-4490    Fax: 515-239-4771

Dr. Bradley Allan Thorgaard, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3300 Kingman Rd, Ames, IA 50014 Phone: 515-292-8819

Charles Jeffrey Paul, MD Urology Medicare: Medicare Enrolled Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4490    Fax: 515-239-4771

Dr. Garrett Steven Korrect, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Avenue., Mcfarland Clinic. Pc, Ames, IA 50010 Phone: 515-239-4490    Fax: 515-239-4771

Dr. Leo Anthony Milleman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4490    Fax: 515-239-4771

News Archive

Reducing collateral damage to excised tissue: Surgeons study device using radiofrequency energy

Every year more than 100,000 women in the United States undergo a lumpectomy, a conservative procedure to remove cancerous tumors while preserving the breast. The surgeon's goal is to attain a tumor-free, or negative, surgical margin the first time they operate. Current surgical tools may cause heat damage to the tissue samples needed for examination by a pathologist in order to identify the presence of cancerous cells on the edges of tumors.

LiveData awarded a SBIR grant for integrating medical technologies

LiveData, Inc., a leader in real-time data integration and display, has been awarded a Phase II Small Business Innovation Research grant from the U.S. Army Telemedicine and Advanced Technology Research Center (TATRC). LiveData will use the $730,000 grant to develop an integrated clinical environment with CIMIT's Medical Device Plug-and-Play (MD PnP) team.

Cancer chemotherapy changes the function of cells that repair heart injury

Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered.

Anticoagulant drug bivalirudin shows mixed results in MATRIX trial

Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints-a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding-as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

Read more Medical News

› Verified 6 days ago